Russell Investments Group Ltd. Grows Position in Agilent Technologies, Inc. $A

Russell Investments Group Ltd. raised its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 11.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 749,294 shares of the medical research company’s stock after purchasing an additional 75,811 shares during the quarter. Russell Investments Group Ltd. owned about 0.27% of Agilent Technologies worth $99,529,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in A. SHP Wealth Management purchased a new stake in shares of Agilent Technologies during the fourth quarter valued at $26,000. Core Wealth Advisors LLC acquired a new position in shares of Agilent Technologies in the 4th quarter valued at $26,000. Navalign LLC purchased a new position in Agilent Technologies in the 4th quarter worth $27,000. MV Capital Management Inc. purchased a new position in Agilent Technologies in the 4th quarter worth $28,000. Finally, Entrust Financial LLC acquired a new stake in Agilent Technologies during the 4th quarter worth about $31,000.

Wall Street Analyst Weigh In

Several analysts have weighed in on A shares. TD Cowen boosted their price target on Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Weiss Ratings raised Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Wolfe Research reaffirmed a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Sunday, August 2nd. Finally, Wells Fargo & Company cut their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Thursday, May 28th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, Agilent Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $160.24.

Agilent Technologies Price Performance

NYSE:A opened at $148.55 on Friday. The firm’s fifty day moving average is $135.38 and its two-hundred day moving average is $125.56. The firm has a market cap of $41.95 billion, a price-to-earnings ratio of 29.83, a PEG ratio of 2.63 and a beta of 1.25. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $160.27.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. The business had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company’s revenue was up 10.0% on a year-over-year basis. During the same quarter last year, the business posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Research analysts expect that Agilent Technologies, Inc. will post 6.03 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th were issued a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Tuesday, June 30th. Agilent Technologies’s dividend payout ratio (DPR) is 20.48%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.